Re-Vana Therapeutics
Hardik Shah is an Analytical Chemist at Norbrook Laboratories Ltd since December 2022, with previous experience as a Crew Member at McDonald's from November 2021 to November 2022. Hardik conducted research as a Postgraduate Researcher at Queen's University Belfast from June to September 2022, focusing on enhancing antibiotic delivery using cold plasma technology. In leadership roles, Hardik contributed as Joint Director of Media Productions at Rotaract District 3141 and as a Human Resources Development Officer and Vice President at Rotaract Club of VES College of Pharmacy. Educational qualifications include an MSc in Industrial Pharmaceutics from Queen's University Belfast, a Master's in Strategic Management and Leadership Practice from the Chartered Management Institute, and a Bachelor of Pharmacy from Vivekanand Education Society's College of Pharmacy. Additional internships in digital marketing and promotions were completed at CrayDesi and Unschool, respectively.
This person is not in any teams
Re-Vana Therapeutics
Re-Vana Therapeutics is an ocular pharmaceutical and drug delivery company focused on the development and commercialisation of revolutionary long-acting biodegradable drug delivery platforms to treat chronic eye diseases such as age-related macular degeneration, diabetic retinopathy, glaucoma and ocular infections.